Bayer Aktiengesellschaft
(OTC) BAYRY
Bayer Aktiengesellschaft Financials at a Glance
Market Cap
$43.42B
Revenue (TTM)
$45.47B
Net Income (TTM)
$3.58B
EPS (TTM)
$-1.11
P/E Ratio
-9.97
Dividend
$0.03
Beta (Volatility)
0.57 (Low)
Dividend
$0.03
Beta (Volatility)
0.57 (Low)
Price
$11.05
Volume
974,418
Open
$11.18
Price
$11.05
Volume
974,418
Open
$11.18
Previous Close
$11.05
Daily Range
$10.92 - $11.44
52-Week Range
$5.30 - $14.85
Dividend
$0.03
Beta (Volatility)
0.57 (Low)
Price
$11.05
Volume
974,418
Open
$11.18
Previous Close
$11.05
Daily Range
$10.92 - $11.44
52-Week Range
$5.30 - $14.85
BAYRY News
How AI Is Used in Healthcare
BAYRY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bayer Aktiengesellschaft
Industry
Pharmaceuticals
Sector
Health CareEmployees
88,078
CEO
William N. Anderson
Website
www.bayer.comHeadquarters
Leverkusen, 51368, DE
BAYRY Financials
Key Financial Metrics (TTM)
Gross Margin
59%
Operating Margin
15%
Net Income Margin
-8%
Return on Equity
-14%
Return on Capital
9%
Return on Assets
-3%
Earnings Yield
-10.03%
Dividend Yield
0.00%
Payout Ratio
-3.51%
Stock Overview
Market Cap
$43.42B
Shares Outstanding
3.93B
Volume
974.42K
Short Interest
0.00%
Avg. Volume
1.14M
Financials (TTM)
Gross Profit
$25.92B
Operating Income
$6.68B
EBITDA
$10.57B
Operating Cash Flow
$4.39B
Capital Expenditure
$2.39B
Free Cash Flow
$2.00B
Cash & ST Invst.
$7.85B
Total Debt
$37.43B
Bayer Aktiengesellschaft Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.33B
-3.4%
Gross Profit
$6.87B
+14.4%
Gross Margin
60.65%
N/A
Market Cap
$43.42B
N/A
Market Cap/Employee
$479.35K
N/A
Employees
90,587
N/A
Net Income
$3.72B
-1011.0%
EBITDA
$2.02B
+20.7%
Quarterly Fundamentals
Net Cash
$29.57B
+9.3%
Accounts Receivable
$12.18B
+23.1%
Inventory
$12.37B
-7.7%
Long Term Debt
$31.80B
-10.4%
Short Term Debt
$5.63B
+8.1%
Return on Assets
-3.27%
N/A
Return on Invested Capital
8.87%
N/A
Free Cash Flow
$2.78B
-28.6%
Operating Cash Flow
$3.56B
-28.7%